How has deep brain stimulation of thalamic nuclei been studied for epilepsy?

Created from Britannica articles using AI. AI can make mistakes, so verify using Britannica articles.

Diagram of a human brain showing a median sagittal section, highlighting the fourth ventricle and cerebellum in the hindbrain, with labeled anatomical structures including the pons, medulla oblongata, and central canal of the spinal cord. — thalamus Sagittal section of the human brain, showing structures of the cerebellum, brainstem, and cerebral ventricles.

Deep brain stimulation (DBS) of specific thalamic nuclei has been studied as a therapeutic intervention for patients with medically refractory epilepsy, a condition characterized by abnormal and recurrent cortical discharges.1

Research, including both animal studies and human trials, has focused on two primary targets:

Anterior Nucleus: Due to its strong connectivity with limbic structures and the medial temporal lobe, stimulation of this nucleus has been shown to reduce seizure frequency in patients with refractory partial epilepsies.1
Intralaminar Nuclei: Stimulation of nuclei such as the centromedian nucleus is utilized because of their diffuse projections to the cerebral cortex. This approach has also demonstrated effectiveness in decreasing seizure frequency for patients with medically refractory forms of the disorder.1

By modulating these thalamic pathways, deep brain stimulation aims to disrupt the abnormal neural activity associated with seizures, offering a potential surgical alternative for those who do not respond to traditional medication.1